TSE:4502Pharmaceuticals
A Look At Takeda Pharmaceutical (TSE:4502) Valuation As New CEO And Transformation Plan Take Shape
Takeda Pharmaceutical (TSE:4502) is in the spotlight after appointing Julie Kim as CEO and outlining a transformation plan focused on cost savings, margin improvements, and upcoming product launches that could reshape how investors view the stock.
See our latest analysis for Takeda Pharmaceutical.
At a share price of ¥4,926, Takeda’s recent 30 day share price return is down 6% and the 90 day share price return is down 13%, yet the 1 year total shareholder return of 19% signals longer term...